Short Pulse Duration High-Power Laser Photocoagulation during Vitrectomy for Diabetic Retinopathy Reduces Postoperative Inflammation.
The aim of this preliminary study was to determine the effectiveness of short pulse duration, high-power laser photocoagulation (PC) during vitrectomy for diabetic retinopathy (DR).The effects of short pulse duration PC with power of 340-360 mW and duration of 0.02 second were compared to conventional PC with power of 120-150 mW and duration of 0.2 second. The degree of inflammation was quantified by laser flare cell photometry before and at 1 day, 1 week, 4 week, and 12 weeks postoperatively. Twenty-two eyes of 22 consecutive patients were studied. Ten eyes were treated with short pulse duration PC and 12 eyes with conventional PC. The total energy was significantly lower in the short pulse duration PC group than in the conventional PC group (P = 0.007). The flare cell values were not significantly different between the two groups after 1 day, but at 1 week, the flare cell value was significantly lower in the short pulse duration PC group than in the conventional PC group (P = 0.04). This difference was also present at 4 and 12 weeks (P<0.05). The significant lower inflammation after short pulse duration PC than conventional PC indicates that the short pulse duration PC protocol should be considered to treat DR.
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Masahiko
M
Sugimoto
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Atsushi
A
Ichio
Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Mineo
M
Kondo
D000368:Aged; D003930:Diabetic Retinopathy / Q000601:surgery*; D006801:Humans; D007249:Inflammation / Q000453:epidemiology / Q000517:prevention & control*; D017075:Laser Coagulation / Q000379:methods* / Q000534:rehabilitation; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control*; D011184:Postoperative Period; D012173:Retinitis / Q000453:epidemiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000009:adverse effects* / Q000379:methods / Q000534:rehabilitation